Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons. - Lode HN; Holko P; Wieczorek A; Śladowska K; Siebert N; Valteau-Couanet D; Garaventa A; Cañete A; Anderson J; Yaniv I; Ash S; Moreno L; et al. (Frontiers in oncology, 2026)